ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Honeybourne, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Honeybourne, D.
Eur Respir J 2002; 20:789
Copyright ©ERS Journals Ltd 2002


Survey of flexible fibreoptic bronchoscopy in the UK

D. Honeybourne

Dept of Respiratory Medicine, Birmingham Heartlands Hospital, Birmingham, UK

To the Editor:

The survey of flexible fibreoptic bronchoscopy in the United Kingom by Smyth and Stead 1 was based on a questionnaire and is therefore completely reliant on the memories' of physicians who have carried out bronchoscopies. Unfortunately, it quotes guidelines that are out of date and indeed does not reference the latest British Thoracic Society guidelines which were published 9 months before the paper was accepted for publication 2. The survey had a modest response rate of 60%, but nevertheless there were some interesting results.

Many practices are not in keeping with the latest British Thoracic Society guidelines. For instance many patients were fasted for longer than the recommended 4 h before the procedure 3. There was unnecessary checking of blood clotting measurements by 18% of respondents and 29% used an antimuscarinic agent despite good evidence that this is unnecessary 4. The authors of the survey imply that electrocardiogram (ECG) and blood pressure monitoring during the procedure should be carried out, but unless there is evidence of unstable cardiovascular disease there is no evidence that this is indicated routinely. The survey did highlight the need to improve the use of protective equipment worn by staff during the procedure, as has been reported previously 5.

At least two published studies have shown that the risk of pneumothorax following transbronchial biopsy without fluoroscopy for diffuse lung disease such as sarcoidosis is low (3.5% in one large study 6). About 50% of patients with a pneumothorax after transbronchial biopsy required drainage 7. Another published study showed no increased risk of pneumothorax in patients with suspected sarcoidosis undergoing transbronchial lung biopsy without fluoroscopy compared to those with fluoroscopy 8. One of the problems with postal questionnaires is that it may not be possible for respondents to remember whether transbronchial biopsies were being carried out for diffuse or localised peripheral lung lesions. There are, however, obvious potential advantages of fluoroscopy when carrying out transbronchial biopsies in patients with localised lesions, but many centres now use a trans-thoracic needle biopsy performed with computed tomography scanning. The conclusion from this survey, that the use of radiographic screening during transbronchial lung biopsy is associated with a lower risk of pneumothorax requiring chest tube drainage, is suspect.

It was disappointing to see that over one third of respondents did not routinely obtain biopsies, washings and brushings when a visible tumour was present, as use of all three has been shown to improve the diagnostic rate 9. This survey has however highlighted areas that need improvement based upon evidence-based guidelines such as those recently published.

References

  1. Smyth CM, Stead J. Survey of flexible fibreoptic bronchoscopy in the United Kingdom. Eur Respir J 2002;19:458–463.[Abstract/Free Full Text]
  2. British Thoracic Society Guidelines on Flexible Bronchoscopy. Thorax 2001;56:Suppl. I, i1–i21.[Free Full Text]
  3. Greenfield SM, Webster GJM, Vicary FR. Drinking before sedation. BMJ 1997;314:162–168.[Free Full Text]
  4. Williams TJ, Brooks T, Ward C. The role of atropine premedication in fiberoptic bronchoscopy using intravenous midazolam sedation. Chest 1998;113:1394–1398.[Abstract/Free Full Text]
  5. Honeybourne D, Neuman C. An audit of bronchoscopy practice in the United Kingdom: a survey of adherence to national guidelines. Thorax 1997;52:709–713.[Abstract]
  6. Milman N, Munch E, Faurschou P, et al. Fiberoptic bronchoscopy in local anaesthesia. Indications, results and complications in 1,323 examinations. Acta Endoscopica 1993;23:151–162.
  7. Pue C, Pacht E. Complications of fiberoptic bronchoscopy at a university hospital. Chest 1995;107:430–432.[Abstract/Free Full Text]
  8. Puar H, Young R, Armstrong E. Bronchial and transbronchial lung biopsy without fluoroscopy in sarcoidosis. Chest 1985;87:303–306.[Abstract/Free Full Text]
  9. Mak VHF, Johnston IDA, Hetzel MR, et al. Value of washings and brushings at fibreoptic bronchoscopy in the diagnosis of lung cancer. Thorax 1990;45:373–376.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Honeybourne, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Honeybourne, D.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS